Anisodine Hydrobromide

DRUG3 trials

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University, Capital Medical University

Conditions

Acute Ischemic StrokeMigraine With AuraMigraine Without Aura

Phase 1

Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL)

Active, not recruitingNCT07513233

Capital Medical UniversityAcute Ischemic Stroke

Start: 2026-04-28End: 2026-11-20Target: 92Updated: 2026-08-24

Phase 2

Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL-2)

RecruitingNCT07800572

Capital Medical UniversityAcute Ischemic Stroke

Start: 2026-09-06End: 2027-03-31Target: 204Updated: 2026-09-09

Phase 3

Anisodine Hydrobromide For The Preventive Treatment Of Episodic Migraine

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityMigraine With Aura, Migraine Without Aura

Start: 2023-10-30End: 2025-12-31Target: 288Updated: 2024-02-28